Skip to main content

Table 1 Antimicrobial resistance threat data as reported by CDC in 2019

From: Nanobiotics against antimicrobial resistance: harnessing the power of nanoscale materials and technologies

Level of concern to human health

Bacteria

Approximate number of deaths/year (year)

Urgent threat

Carbapenem-resistant Acinetobacter baumannii

700 (2017)

Clostridioides difficile

12,800 (2017)

Carbapenem-resistant Enterobacterales

1100 (2017)

Drug-resistant Neisseria gonorrhoeae

550,000 infections/year (2017)

Serious threat

Drug-resistant Campylobacter

70 (2017)

Extended spectrum β-lactamase (ESBL)-producing Enterobacterales

9100 (2017)

Vancomycin-resistant Enterococcus

5400 (2017)

MDR P. aeruginosa

2700 (2017)

Drug-resistant nontyphoidal Salmonella

70 (2017)

Drug-resistant Salmonella serotype Typhi

< 5 (2017)

Drug-resistant Shigella

< 5 (2017)

Methicillin-resistant Staphylococcus aureus (MRSA)

10,600 (2017)

Drug-resistant Streptococcus pneumonia

3600 (2014)

Drug-resistant Tuberculosis

62 (2017)

Concerning threats

Erythromycin-resistant Group A Streptococcus (GAS)

450 (2017)

Clindamycin-resistant group B Streptococcus (GBS)

720 (2016)

Watch list

Drug-resistant Mycoplasma genitalium

Drug-resistant Bordetella pertussis